Approved MS Drug Shows Promise as New Alzheimer’s Therapy
In a pivotal breakthrough, researchers from the University of Kentucky have revealed that ponesimod, an FDA-approved drug for multiple sclerosis (MS), displays significant potential as a treatment for Alzheimer’s disease.